Haffkine Bio-Pharmaceutical Corporation Limited.
  • 2010 March
    Acceptibility in principle of Bivalent types 1 &3 oral poliomyelitis vaccine I.P. (bOPV1&3) produced by Haffkine Bio-Pharmaceutical Corporation Ltd. for purchase by UN agencies.
  • 2009-2010
    The Company recorded a highest ever group tunover of approx, Rs 183 Crores which was the significant achievement in the annals of the Sales & Marketing history of the company which was possible only the receipt of orders from UNICEF for tOPV & mOPV1 in significant quantities.
  • 2008
    company hase Initiated the process of revamping of the Pharmaceutical dept., at HBSCL, ATS, Pimpri & HAPL Jalgaon to comply with revised Schedule 'M, GMP requirement Company obtained UN Accreditation for mOPV1
  • 2004
    Revamping of OPV facility at par with the guidelines for UN Pre-qualification accomplished Experimental batches of Acetone killed Typhoid vaccine cleared by CDL, Kasuali.
  • 2001
    Successful completion of Lyophilization project at ATS, Pimpri.
  • 2000
    Restart of Anti Rabies Serum manufacturing initiated.
  • 1999
    Obtaining UNICEF order for supply of oral polio vaccine.
  • 1999
    Implementation of WHO-GMP guidelines for certification for oral polio vaccine facilities.
  • 1999
    Vermiculture from horse dung at Pimpri.
  • 1998
    Launching of Lyophilisation project at Pimpri